These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7058201)

  • 1. [Inter- and intra-individual variations on the disposition of piroxicam. Pharmacokinetics in healthy man and the patient with renal insufficiency].
    Dupont D; Dayer P; Balant L; Gorgia A; Fabre J
    Pharm Acta Helv; 1982; 57(1):20-6. PubMed ID: 7058201
    [No Abstract]   [Full Text] [Related]  

  • 2. Piroxicam pharmacokinetics in man: aspirin and antacid interaction studies.
    Hobbs DC; Twomey TM
    J Clin Pharmacol; 1979; 19(5-6):270-81. PubMed ID: 89124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetic study of piroxicam in healthy man after administration of a single dose equal to 20 mg, by the oral route].
    Fourtillan JB; Dubourg D
    Therapie; 1983; 38(2):163-70. PubMed ID: 6636023
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolism of piroxicam by laboratory animals.
    Hobbs DC; Twomey TM
    Drug Metab Dispos; 1981; 9(2):114-8. PubMed ID: 6113108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antirheumatic treatment in old age and its effect on kidney function].
    Jansen W
    Med Klin; 1981 Aug; 76(17):476-8. PubMed ID: 7278786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetic study of piroxicam following oral and rectal administration].
    Acerbi D; Daccò L; Palummeri E
    Boll Chim Farm; 1983 Sep; 122(9):19S-27S. PubMed ID: 6689401
    [No Abstract]   [Full Text] [Related]  

  • 7. Disposition of ampiroxicam, a prodrug of piroxicam, in man.
    Falkner FC; Twomey TM; Borgers AP; Garg D; Weidler D; Gerber N; Browder IW
    Xenobiotica; 1990 Jun; 20(6):645-52. PubMed ID: 2219958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of piroxicam, a new nonsteroidal anti-inflammatory agent, under fasting and postprandial states in man.
    Ishizaki T; Nomura T; Abe T
    J Pharmacokinet Biopharm; 1979 Aug; 7(4):369-81. PubMed ID: 512843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of isoxicam in man following oral administration.
    Kölle EU; Hengy H; Vollmer KO
    Arzneimittelforschung; 1983; 33(4):582-6. PubMed ID: 6683539
    [No Abstract]   [Full Text] [Related]  

  • 10. [Scientific basis of piroxicam (Felden). Pharmacological properties and mechanism of action].
    Wiseman EH
    Wien Med Wochenschr; 1980; 130 Spec No():27-31. PubMed ID: 7456463
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis and antiinflammatory activity of metabolites of piroxicam.
    Lombardino JG
    J Med Chem; 1981 Jan; 24(1):39-42. PubMed ID: 7205872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetics of dibekacin in patients with chronic renal impairment].
    Viotte G; Leroy A; Godin M; Fillastre JP
    Nouv Presse Med; 1982 Nov; 11(46):3414-8. PubMed ID: 7155849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiinflammatory activity and bioavailability of percutaneous piroxicam.
    Schiantarelli P; Cadel S; Acerbi D; Pavesi L
    Arzneimittelforschung; 1982; 32(3):230-5. PubMed ID: 7200781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of isoxicam in two pharmaceutical formulations.
    Gras J; Perez MC; Fernandez E; Gelpi E
    Boll Chim Farm; 1985 May; 124(5):190-5. PubMed ID: 4052240
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative pharmacokinetics of antrafenine in healthy volunteers and in patients with chronic renal failure (author's transl)].
    Rovei V; Leroy A; Sauvanet JP; Braithwaite R; Coquelin JP; Gomeni R; Morselli PL; Fillastre JP
    Therapie; 1981; 36(1):21-6. PubMed ID: 7233368
    [No Abstract]   [Full Text] [Related]  

  • 16. [Piroxicam for the therapy of arthritis and rheumatism of the soft tissues (author's transl)].
    Knüsel O
    Schweiz Rundsch Med Prax; 1981 Dec; 70(51):2316-21. PubMed ID: 6949149
    [No Abstract]   [Full Text] [Related]  

  • 17. [Serum concentrations of piroxicam in relation to clinical effectiveness in patients with chronic polyarthritis].
    Siegmeth W
    Wien Med Wochenschr; 1980; 130 Spec No():31-6. PubMed ID: 7456464
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clofibrate pharmacokinetics in chronic renal failure (author's transl)].
    Millart H; Lavaud S; Brunois JP; Lamiable D; Choisy H; Chanard J
    Therapie; 1980; 35(6):705-16. PubMed ID: 7233360
    [No Abstract]   [Full Text] [Related]  

  • 19. Single-dose and steady-state pharmacokinetics of piroxicam in elderly vs young adults.
    Darragh A; Gordon AJ; O'Byrne H; Hobbs D; Casey E
    Eur J Clin Pharmacol; 1985; 28(3):305-9. PubMed ID: 4007035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analgesic effectiveness of Felden (piroxicam) in chronic polyarthritis. A placebo controlled study].
    Tausch G
    Wien Med Wochenschr; 1980; 130 Spec No():57-61. PubMed ID: 7456467
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.